- Home
- ATYR vs CGO Comparison
ATYR vs CGO Comparison
Compare ATYR & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATYR | CGO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 112.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ATYR | CGO |
|---|---|---|
| Price | $0.86 | $12.59 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $3.67 | N/A |
| AVG Volume (30 Days) | ★ 934.5K | 27.8K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $10.13 |
| 52 Week High | $7.29 | $12.79 |
Technical Indicators
Market Signals| Indicator | ATYR | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 64.97 |
| Support Level | $0.68 | $11.37 |
| Resistance Level | $0.86 | N/A |
| Average True Range (ATR) | 0.05 | 0.22 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 87.20 | 86.63 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.